| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics, Inc. | John F. Crowley | Director | Jan 12, 2022 | Buy | $9.72 | 5,000 | 48,575 | 5,000 | Jan 13, 2022, 07:53 PM | |
| NTLA | Intellia Therapeutics, Inc. | John F. Crowley | Director | Oct 11, 2021 | Option/RSU Exercise | $18.83 | 2,500 | 47,075 | 4,594 | Oct 13, 2021, 04:15 PM | |
| NTLA | Intellia Therapeutics, Inc. | John F. Crowley | Director | Oct 11, 2021 | Sale | $119.55 | 2,500 | 298,875 | 2,094 | Oct 13, 2021, 04:15 PM | |
| NTLA | Intellia Therapeutics, Inc. | John F. Crowley | Director | Oct 05, 2021 | Option/RSU Exercise | $18.83 | 10,000 | 188,300 | 12,094 | Oct 07, 2021, 05:41 PM | |
| NTLA | Intellia Therapeutics, Inc. | John F. Crowley | Director | Oct 05, 2021 | Sale | $130.54 | 10,000 | 1,305,391 | 10,814 | Oct 07, 2021, 05:41 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More